Kristin Stafford, CPA

Kristin Stafford became a director of Novocure in March 2023. She is currently Chief Financial Officer of Zymeworks Inc., a position she has held since April 2026. Prior to this she served as Senior Vice President, Chief Accounting Officer for Royalty Pharma plc, from December 2018 and as Vice President, Finance of Royalty Pharma and Chief Financial Officer of BioPharma Credit plc, an affiliate of Royal Pharma, from 2016 to 2018. Ms. Stafford is a Certified Public Accountant and holds a bachelor of science degree in business administration from Sonoma State University.